Previous 10 | Next 10 |
Image source: The Motley Fool. Zynex, Inc (NASDAQ: ZYXI) Q4 2019 Earnings Call Feb 27, 2020 , 4:15 p.m. ET Operator Continue reading
Zynex, Inc. (ZYXI) Q4 2019 Earnings Conference Call February 27, 2020 4:15 PM ET Company Participants Thomas Sandgaard – Founder, Chairman and Chief Executive Officer Dan Moorhead – Chief Financial Officer Conference Call Participants Boobalan Pachaiyappan ...
Zynex (NASDAQ: ZYXI ): Q4 GAAP EPS of $0.09 beats by $0.01 . More news on: Zynex, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
ENGLEWOOD, Colo. , Feb. 27, 2020 /PRNewswire/ -- 2019 Full Year Revenue increased 42% year over year to $45.5 million Net income $9.5 million ; Diluted EPS $0.28 2019 Revenue, net income and Adjusted EBITDA are the highest in Company history Adjusted EBITDA incr...
ENGLEWOOD, Colo. , Feb. 25, 2020 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics...
ENGLEWOOD, Colo., Feb. 18, 2020 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagn...
ENGLEWOOD, Colo. , Feb. 3, 2020 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics...
Thinly traded micro cap Zynex ( ZYXI +20.4% ) is up on a healthy 43x surge in volume in response to a recent acceleration in its business. More news on: Zynex, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Gainers: Trillium Therapeutics (NASDAQ: TRIL ) +106% . More news on: Trillium Therapeutics Inc., Applied Genetic Technologies Corporation, Genetic Technologies Limited, Stocks on the move, Read more ...
ENGLEWOOD, Colo. , Jan. 9, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today an...
News, Short Squeeze, Breakout and More Instantly...
Zynex Reports Second Quarter 2024 Financial Results PR Newswire Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the ma...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...